Cargando…
Cardiovascular risk prediction in the elderly
Heart failure (HF) in the elderly, besides being a leading cause of mortality and morbidity, is rapidly increasing in prevalence with patients aged 65 and older accounting for more than 75% of heart failure hospitalizations. Elderly patients have historically been unrepresented in clinical HF trials...
Autores principales: | Kumar, Kartik, Afonso, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558575/ https://www.ncbi.nlm.nih.gov/pubmed/31217795 http://dx.doi.org/10.11909/j.issn.1671-5411.2019.05.010 |
Ejemplares similares
-
Atorvastatin and cardiovascular risk in the elderly – patient considerations
por: Acharjee, Subroto, et al.
Publicado: (2008) -
Cardiovascular Risk Factors and Physical Activity for the Prevention of Cardiovascular Diseases in the Elderly
por: Ciumărnean, Lorena, et al.
Publicado: (2021) -
Cardiovascular prevention in elderly patients
por: Bonanad, Clara, et al.
Publicado: (2022) -
Novel biomarkers for cardiovascular risk prediction
por: Wang, Juan, et al.
Publicado: (2017) -
Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
por: Long, Sydney B, et al.
Publicado: (2011)